Inappropriate ADH Syndrome - 11 Studies Found Completed : Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study : Inappropriate ADH Syndrome : 2016-03-24 : Other: Induced hypotonic hyponatremia - SIAD model Withdrawn : Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine : Syndrome of Inappropriate ADH-secretion : 2006-03-01 : Procedure: fluid restriction for 14 days (15ml fluid per kg weight) Terminated : A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia : Hyponatremia Inappropriate ADH Syndrome : 2008-07-31 : Drug: Satavaptan tablets Terminated : Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia : Hyponatremia Dilutional Hyponatremia : 2010-10-22 : Drug: tolvaptan 15 mg titrated Completed : An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain : Hyponatremia Syndrome of Inappropriate ADH (SIADH) Secretion : 2015-09-07 Completed : An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH : Hyponatremia Syndrome of Inappropriate ADH (SIADH) Secretion : 2015-09-07 Completed : An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy : Hyponatremia Syndrome of Inappropriate ADH (SIADH) Secretion : 2015-10-06 Completed : "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia : Hyponatremia Water Intoxication Inap : 2005-09-13 : Drug: Tolvaptan Completed : “SALT Trial” Study of Ascending Levels of Tolvaptan in Hyponatremia : Hyponatremias Water Intoxication Ina : 2003-11-07 : Drug: tolvaptan Completed : Subclassification of the Syndrome of Inappropriate ADH Secretion : Hyponatremia : 2011-04-21 Next >>>
